Search | IOVS | ARVO Journals

iovs

Issues
Topics
For Authors
About
- Editorial Board

Journals Home

MANAGE ALERTS

Forgot password?

Create an Account

To View More...

Purchase this article with an account.

or

Subscribe Now

Issues
Topics
For Authors
About
- Editorial Board

Narrow View

NARROW

Content Type

Meeting Abstract (8)
Journal Articles (3)

Journal

Investigative Ophthalmology & Visual Science (11)

Article Type

ARVO Annual Meeting Abstract (8)
Retina (2)
Clinical Trials (1)

Topics

Genetics (3)
Retina (3)
Eye Anatomy and Disorders (2)

Tags

docosahexaenoic acids (3)
fatty acids (2)
placebos (2)
retinitis pigmentosa (2)
x-linked inheritance (2)
adverse event (1)
blood chemical analysis (1)
dna, complementary (1)
fetus (1)
gene expression (1)

Specify Date Range

From: To: Apply

Showing 1 – 11 of 11

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Clinical Trials October 2015

Docosahexaenoic Acid Slows Visual Field Progression in X-Linked Retinitis Pigmentosa: Ancillary Outcomes of the DHAX Trial

PDF

Dennis R. Hoffman; Dianna K. Hughbanks-Wheaton; Rand Spencer; Gary E. Fish; N. Shirlene Pearson; Yi-Zhong Wang; Martin Klein; Alison Takacs; Kirsten G. Locke; David G. Birch
TAGS: docosahexaenoic acids, placebos, retinitis pigmentosa, visual fields, x-linked inheritance, visual acuity
Invest. Ophthalmol. Vis. Sci.. 2015; 56(11):6646-6653. doi: https://doi.org/10.1167/iovs.15-17786

ARVO Annual Meeting Abstract June 2015

Ancillary Outcomes of the DHAX Trial: Docosahexaenoic Acid (DHA) Supplementation in X-Linked Retinitis Pigmentosa (XLRP)

Dennis R Hoffman; Dianna K H Wheaton; Rand Spencer; Gary Fish; N Shirlene Pearson; Yi-Zhong Wang; Martin Klein; Alison Takacs; Kirsten G Locke; David G Birch

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3803. doi:

Retina August 2014

Safety Assessment of Docosahexaenoic Acid in X-Linked Retinitis Pigmentosa: The 4-Year DHAX Trial

PDF

Dianna K. Hughbanks-Wheaton; David G. Birch; Gary E. Fish; Rand Spencer; N. Shirlene Pearson; Alison Takacs; Dennis R. Hoffman
TAGS: adverse event, docosahexaenoic acids, fatty acids, placebos, plasma, retinitis pigmentosa, safety, x-linked inheritance, blood chemical analysis, lipoproteins
Invest. Ophthalmol. Vis. Sci.. 2014; 55(8):4958-4966. doi: https://doi.org/10.1167/iovs.14-14437

Includes: Supplemental Content

ARVO Annual Meeting Abstract April 2014

Safety Assessment of High Dose Docosahexaenoic Acid (DHA) Supplementation in a 4-Year Randomized Clinical Trial in X-linked Retinitis Pigmentosa (XLRP)

Dianna K H Wheaton; David G Birch; Gary E Fish; Rand Spencer; N Shirlene Pearson; Alison Takacs; Robbie Baker; Dennis R Hoffman

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1391. doi:

ARVO Annual Meeting Abstract April 2014

Annual decline in visual sensitivity at the edge of the OCT-defined ellipsoid zone (EZ) in patients with RPGR-mediated x-linked Retinitis Pigmentosa (xlRP)

David G Birch; Kirsten G Locke; Martin Klein; Dianna K H Wheaton; Dennis R Hoffman; Donald C Hood

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1398. doi:

ARVO Annual Meeting Abstract April 2014

High Dose Docosahexaenoic Acid (DHA) Supplementation in X-Linked Retinitis Pigmentosa (XLRP): A 4-Year Randomized, Controlled Clinical Trial

Dennis R Hoffman; Dianna K H Wheaton; Gary E Fish; Rand Spencer; N Shirlene Pearson; Alison Takacs; Martin Klein; Kirsten G Locke; David G Birch

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5010. doi:

ARVO Annual Meeting Abstract March 2012

FdOCT Outer Segment Layer (OS) Measures of Progression Over a Two-year Interval in Patients With X-linked Retinitis Pigmentosa (XLRP)

Kirsten G. Locke; Kelly I. Locke; Yuquan Wen; Dennis R. Hoffman; Don C. Hood; David G. Birch

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):4573. doi:

ARVO Annual Meeting Abstract March 2012

Perceived Stress And Biochemical Stress In X-linked Retinitis Pigmentosa (XLRP)

Dianna K. Wheaton; Megan Fish; Alison Takacs; Jessica Fernandez; Dennis R. Hoffman

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):4588. doi:

ARVO Annual Meeting Abstract April 2011

Assessment of Phenotypic Variability Among Female Carriers of X-linked Retinitis Pigmentosa (xlRP) due to RPGR Mutations

Kaylie D. Webb; Hemaxi M. Patel; Sara J. Bowne; Lori S. Sullivan; Abigail T. Fahim; Stephen P. Daiger; Dennis R. Hoffman; David G. Birch; Dianna K. Wheaton

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4981. doi:

ARVO Annual Meeting Abstract April 2011

FdOCT Measures Of Progression Over A One Year Interval In Patients With X-linked Retinitis Pigmentosa (XLRP)

Kirsten G. Locke; Kelly I. Locke; Yuquan Wen; Donald C. Hood; Dennis R. Hoffman; David G. Birch

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4986. doi:

Retina July 2003

Gene Expression Analysis in Human Fetal Retinal Explants Treated with Docosahexaenoic Acid

PDF

Cecilia V. Rojas; Jessica I. Martínez; Ingrid Flores; Dennis R. Hoffman; Ricardo Uauy
TAGS: docosahexaenoic acids, fatty acids, fetus, gene expression, genes, proteins, rna, messenger, dna, complementary
Invest. Ophthalmol. Vis. Sci.. 2003; 44(7):3170-3177. doi: https://doi.org/10.1167/iovs.02-1138

« Previous

Advertisement

Follow @ARVOiovs

IOVS Home
Issues
Topics
For Authors
About
- Editorial Board

Online ISSN: 1552-5783

Investigative Ophthalmology & Visual Science
Journal of Vision
Translational Vision Science & Technology

JOURNALS HOME
TOPICS
ABOUT ARVO JOURNALS

Copyright © 2023 Association for Research in Vision and Ophthalmology.

Forgot password?

To View More...

Purchase this article with an account.

Create an Account

or

Subscribe Now

×

×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept